In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way
Feb. 1, 1996
In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way the FDA deals with approval of drugs and medical devices. Today, it takes an average of 12 years and $359 million to bring a new drug onto the market. Sen. Nancy Kassebaum, R-Kan., who heads the Senate Labor and Human Resources Committee, is backing legislation that will reform the role of the FDA in the testing and review of new drugs and medical devices. Rep.Thomas Bliley, R-VA, who heads the Ho
In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way the FDA deals with approval of drugs and medical devices. Today, it takes an average of 12 years and $359 million to bring a new drug onto the market. Sen. Nancy Kassebaum, R-Kan., who heads the Senate Labor and Human Resources Committee, is backing legislation that will reform the role of the FDA in the testing and review of new drugs and medical devices. Rep.Thomas Bliley, R-VA, who heads the House Commerce Committee, also promised swift action, saying he`s concerned that American companies and jobs are being forced overseas "where the climate is more conducive to innovation.
If any car could take you from A to B, what made you choose the one you’re driving? Once you determine your wants and needs, purchasing decisions become granular regarding personal...
How can you strengthen case acceptance at your practice? One way is by investing in advanced technology that enables you to make a stronger case for treatment and to provide faster...
Case acceptance is central to the oral health of your patients and the financial health of your practice. Click here to discover how the right investments in technology can help...
Hear from 3 seasoned Patterson representatives as they share their firsthand knowledge of what an investment in equipment and technology means to a practice.
